CYTH - Cyclo Therapeutics, Inc.
0.7206
0.010 1.374%
Share volume: 188,267
Last Updated: 03-25-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$0.71
0.01
0.01%
View ratios
| Fiscal Date | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 12-18-2024 | 05-15-2024 | 08-14-2024 | 11-14-2024 | |
| Cash flow financing | 13.987 M | -69.281 K | 1.975 M | 7.999 M | |
| Other financing cash flows | 14.840 M | 0.000 | 0.000 | 0.000 | |
| Cash flow | 16.022 M | -6.251 M | 0.000 | 0.000 | |
| Net income | -900.041 K | -4.343 M | -5.981 M | -8.833 M | |
| Depreciation | 12.745 K | 2.177 K | 2.177 K | 2.177 K | |
| Changes in inventories | 0.000 | -11.822 K | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -2.420 K | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | -592.569 K | -69.281 K | -25.234 K | -1.396 K | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 16.022 M | -6.251 M | -1.873 M | -193.802 K |